Advanced Cholesterol Clinic
Medical Director: Rolando L. deGoma, MD, FACC, FNLA
Site Navigation
[Skip]
Home
Closing the Wide Treatment Gap
Earlier Coronary Plaque Detection
My Plaque Stabilization-Regression Therapy
Metabolic Switching
About Us
Patient Mentoring
MC Cost Comparison Dr. deGoma vs All Other Cardiologists Nationally
ACC President 2004
ACC President 2015
NJ Cardiac Hospitalization Rate
CV Risk Assessment
Dual Approach
Heart Attack is Number 1
Stroke is Number 3
PAD Mortality
Heart and Stroke Same Process
2015 AHA MI Statistics
2009 AHA Statistics
Treatment Guidelines
Mary - CHD Risk Equivalent
Jim - CHD Risk Equivalent
3 of 5 is Metabolic Syndrome
LDL Cholesterol
An LDL Particle
LDL-p
Lp(a)
Where does LDL come from?
More LDL Particles, More Plaques
LDL-c vs LDL-P
Plaques
LDL Entering Artery Wall
Cholesterol-fllled plaque
Multiple Plaques at Different Stages of Development
The Main Culprit - Sudden Plaque Rupture
Carotid Plaque Erosion
Urgency of Early Detection - In 1 out of 4 people, it is sudden death.
Detect Your Plaques Earlier and Live
Coronary Calcification Pathology Slide
Plaque Imaging
Coronary arteriogram Not Detecting Plaque
Coronary Calcifications
Sudden Plaque Rupture
Most Heart Attacks Are Caused By Rupture of Mild to Moderate Plaques
Natural Course of Heart Disease
Zero Coronary Calcium Score
High Coronary Calcium Score
Dr. R. deGoma CACS 2004
Zero vs 1 - 100 CACScore
About Statins
Advanced Cholesterol Therapy is the Cornerstone
Diabetes Steno2 Trial Results
The Statins
How Statin Works in Liver
How Statin Works
Benefits of Statin
Safety of Statin is Well Established
No Link Between Statins and Cognitive Decline
Non-lipid effects of statin
HDL-c In Reverse Cholesterol Transport
Statin Trials - Primary Prevention
AFCAPS TEXCAPS - Primary Prevention
JUPITER Trial
ASCOT Trial - Time to Benefit
Statin Trials - Secondary Prevention
The 1994 Landmark 4S Trial
Statin Trials and Clinical Outcomes
Statin and Stroke Prevention
Statin Presecribed to Less Than Half of Stroke Patients
Combination Therapy
IMPROVE IT MOA
IMPROVE IT: LDLc 70 vs 50 mg/dL
IMPROVE IT
HATS Trial
FATS Trial
POSCH Surgical Trial
AIM HIGH Trial
Stablization-Regression Plaque Therapy
Many Plaques, Some More Likely To Rupture Than Others
Plaque Therapy
Most Heart Attacks Are Not Caused By Plaques Causing Severe Obstruction
IVUS vs Arteriogram
Inducing Plaque Regression
Coronary Calcium Score Over 13 years of Follow Up
MRI Plaque Regression
Dr. R. deGoma Lipid Profile 2013
Dr. R. deGoma Lipid Profile June 2017
Dr. R. deGoma Lipid Profile Nov 2017
COURAGE Trial
COURAGE Trial Patient Characteristics
COURAGE Trial Conclusion
Coronary Arteries Years Before a Heart Attack
Stent Treats One Plaque
COURAGE Trial LDL-c Levels
Post COURAGE -A Call for Fewer Stents
Improving Outcomes
Get with The Guidelines
Lost Decade 2000-2010
The Million Hearts Initiative Grand Round
Beginning of the End of Most Heart Disease
Public and Physician Education
Performance Data
Prevention is our Passion
Hearts and Stroke and the Bottom Line
L-TAP Study - Wide Treatment Gap Nationwide
PDA Reminder Did Not Help
Traditional Lipid Clinics vs Conventional Care
ACC President - Treatment will advance to prevention
Performance Data in Non-Traditional Clinic Clinic
Mean LDLc NJPCCC and 4S
Closing The Treatment Gap
2013 Ten Year ASCVD Risk Calculator
Annual Increase in Coronary Calcium Score
Reducing Cost
Public and Physician Education
Cost Effectiveness of Heart Attack and Stroke Prevention
Without Prevention - Increasing Revenues
With Stabilization-Regression Therapy - Shrinking Revenues
Higher Risk Higher Consumption
Benefits of Preventive Treatment
Consequences of Lack of Preventive Care
The Impact of Preventing Most Heart Attacks and Strokes
Cost Effectiveness of Medical Theapy
Cost Savings from Cholesterol Reduction
Shorter Door To Ballon Time Did Not Reduce Deaths
Women and Heart Disease
CVD Mortality in Men and Women
2001 Ten Year Framingham Risk Score
Heart Facts Women Need To Know
Diabetes Causes Plaque Build Up
Prevalence of Diabetes
Diabetes is a CHD Risk Equivalent
Dr deGoma LP 2013
Diabetes and Statin1
Diabetes and Statin2
Diabetes and Statin3
Diabetes HgbA1c and MI
Look AHEAD Halted due to Futility
Look AHEAD Primary Outcomes
Look AHEAD Secondary Outcomes
NJ Preventive Cardiology Closed The Treatment Gap 2006
NJ Cardiovascular Health Statistics
Video: Where LDL comes from and how statin works
Atrial Fibrillation
AFib Ablation
Abnormal nuclear heart scan
Dr. R deGoma's Journey to Prevention - National Lipid Association Member Spotlight 2010.pdf
Apr 26, 2014 at 2:16 PM
© 2020 CholesterolClinic.com
[Back To Top]
